App-Based recovery program aims to get heart bypass patients home sooner

NCT ID NCT06786819

Recruiting now Disease control Sponsor: University of Sao Paulo General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This study tests whether a smartphone app that guides patients through a rapid recovery program (ERAS) can reduce time in the hospital after heart bypass surgery. About 480 adults in Brazil will use the app, which starts before surgery and continues for 30 days after discharge. The goal is to see if this digital approach leads to shorter hospital stays and fewer complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Digital ERAS platform (app-based protocol)
What this could lead to: If successful, this could shorten hospital stays and improve recovery for heart bypass patients, making surgery safer and more efficient.
What could go wrong: This is a relatively small, early-stage study focused on process improvement, not a new drug or cure. Results may not apply to all hospitals or patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC SURGERY CARDIAC SURGERY-CABG DIGITAL HEALTH ERAS

Contacts and locations

Locations

InCor - Instituto do Coração do Hospital das Clínicas da FMUSP
RECRUITING

São Paulo, São Paulo, 05403-900, Brazil
InCor - Instituto do Coração do Hospital das Clínicas da FMUSP
RECRUITING

São Paulo, São Paulo, 05403-900, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.